|
2005 Journal Article First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidinWallace, D. F., Summerville, L., Lusby, P. E. and Subramaniam, V. N. (2005). First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut, 54 (7), 980-986. doi: 10.1136/gut.2004.062018 |
|
2005 Journal Article Identification of ferroportin disease in the Indian subcontinentWallace, D. F., Browett, P., Wong, P., Kua, H., Ameratunga, R. and Subramaniam, V. N. (2005). Identification of ferroportin disease in the Indian subcontinent. Gut, 54 (4), 567-568. doi: 10.1136/gut.2004.060988 |
|
2005 Journal Article Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatusLoh, Eva, Peter, Frank, Subramaniam, V. Nathan and Hong, Wanjin (2005). Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatus. Journal of Cell Science, 118 (6), 1209-1222. doi: 10.1242/jcs.01723 |
|
2005 Journal Article Hemojuvelin (HJV)-associated hemochromatosis: Analysis of HJV and HFE mutations and iron overload in three familiesWallace, Daniel F., Dixon, Jeannette L., Ramm, Grant A., Anderson, Gregory J., Powell, Lawrie W. and Subramaniam, Nathan (2005). Hemojuvelin (HJV)-associated hemochromatosis: Analysis of HJV and HFE mutations and iron overload in three families. Haematologica, 90 (2), 254-255. |
|
2005 Journal Article Ferroportin disease due to the A77D mutation in AustraliaSubramaniam, V. N., Wallace, D. F., Dixon, J. L., Fletcher, L. M. and Crawford, D. H. (2005). Ferroportin disease due to the A77D mutation in Australia. Gut, 54 (7), 1048-1049. doi: 10.1136/gut.2005.069021 |
|
2005 Conference Publication Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver diseaseAnderson, Greg, Frazer, David M., Bridle, Kim R., Macdonald, Graeme A., Smith, Jeffrey L., Turlin, Bruno, Subramaniam, Nathan, Crawford, Darrell H., Powell, Lawrie W. and Ramm, Grant A. (2005). Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease. 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, 10-13 December, 2005. Washington, D.C., USA: American Society of Hematology. |
|
2005 Conference Publication Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.Powell, LW, Dixon, JL, Anderson, GA, Subramaniam, VN, Lincoln, DJ, Fletcher, LM, Crawford, DH, Searle, JW and Ramm, GA (2005). Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.. 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco CA, NOV 11-15, 2005. HOBOKEN: JOHN WILEY & SONS INC. |
|
2004 Journal Article Genetic disorders in gastroenterology and hepatology - HFE gene and hemochromatosisRamm, G. A., Subramaniam, V. N. and Powell, L. W. (2004). Genetic disorders in gastroenterology and hepatology - HFE gene and hemochromatosis. Journal of Gastroenterology and Hepatology, 19 (6), 712-712. doi: 10.1111/j.0815-9319.2004.03499.x |
|
2004 Journal Article Inactivation of the murine Transferrin receptor 2 gene using the Cre recombinase: IoxP systemWallace, Daniel F., Tonks, Ian D., Zournazi, Anna, Kay, Graham F. and Subramaniam, V. Nathan (2004). Inactivation of the murine Transferrin receptor 2 gene using the Cre recombinase: IoxP system. Genesis, 39 (1), 38-41. doi: 10.1002/gene.20023 |
|
2004 Journal Article Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosisWallace, Daniel F., Clark, Roslyn M., Harley, Hugh A. J. and Subramaniam, V. Nathan (2004). Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. Journal of Hepatology, 40 (4), 710-713. doi: 10.1016/j.jhep.2003.12.008 |
|
2004 Journal Article ReplyAnderson, Gregory J., Frazer, David M., Bridle, Kim R., Crawford, Darell H. G., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2004). Reply. Gastroenterology, 126 (2), 616-616. doi: 10.1053/j.gastro.2003.12.054 |
|
2004 Conference Publication The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screeningPowell, L. W., Dixon, J. L., Ramm, G. A., Anderson, G. J., Subramaniam, V. N., Purdie, D. M., Hewett, D. G., Searle, J. W., Fletcher, L. M., Crawford, D. H., Rodgers, H., Khoo, T. L., Cavanaugh, J. A. and Bassett, M. L. (2004). The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening. 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston MA, 29 October - 2 November 2004. HOBOKEN: JOHN WILEY & SONS INC. |
|
2003 Journal Article Ironing out doxorubicin-related cardiotoxicitySubramaniam, V. N. (2003). Ironing out doxorubicin-related cardiotoxicity. Blood, 102 (7), 2317-2318. doi: 10.1182/blood-2003-07-2517 |
|
2003 Journal Article A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patientArdenKE, WallaceDF, DixonJL, SummervilleL, SearleJW, AndersonGJ, RammGA, PowellLW and Subramaniam, V. N. (2003). A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut, 52 (8), 1215-1217. doi: 10.1136/gut.52.8.1215 |
|
2003 Journal Article Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasisBridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H. G., Subramaniam, V. N, Powell, L. W., Anderson, G. J. and Ramm, G. A. (2003). Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet, 361 (9358), 669-673. doi: 10.1016/S0140-6736(03)12602-5 |
|
2003 Conference Publication Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrancePowell, L. W., Dixon, J. L., Hewett, D. G., Purdie, D. M., Ramm, G. A., Anderson, G. J., Subramaniam, N., Fletcher, L. M., Crawford, D. H., Cavanaugh, J. A. and Bassett, M. L. (2003). Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance. 54th Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, United States, 24-28 October 2003. PHILADELPHIA: W B SAUNDERS CO. |
|
2003 Conference Publication Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasisBridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Millard, K. N., Crawford, D. H. G., Subramaniam, V. N., Powell, L. W., Anderson, G. J. and Ramm , G. A. (2003). Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis. Australian Gastroenterology Week, Cairns, Australia, 7-10 October 2003. Carlton South, Vic., Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1746.18.s2.5.x |
|
2003 Conference Publication The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D)Hewett, D. G.., Dixon, J. L., Purdie, D. M., Ramm, G. A., Anderson, G. J., Subramaniam, N., Fletcher, L. M., Crawford, D. H., Cavanaugh, J. A., Bassett, M. L. and Powell, L. W. (2003). The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D). 54th Annual Meeting of the American Association for the Study of Liver Disease, Boston, M.A. USA, 24-28 October 2003. PHILADELPHIA: W B SAUNDERS CO. |
|
2002 Conference Publication Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.Powell, L, Dixon, JL, Ramm, G, Anderson, G, Subramaniam, N, Fletcher, L, Crawford, D, Cavanaugh, J and Bassett, M (2002). Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.. 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Boston Massachusetts, Nov 01-05, 2002. PHILADELPHIA: W B SAUNDERS CO. |
|
2002 Journal Article Novel mutation in ferroponin1 is associated with autosomal dominant hemochromatosisWallace, Daniel F., Pedersen, Palle, Dixon, Jeannette L., Stephenson, Peter, Searle, Jeffrey W., Powell, Lawrie W. and Subramaniam, V. Nathan (2002). Novel mutation in ferroponin1 is associated with autosomal dominant hemochromatosis. Blood, 100 (2), 692-694. doi: 10.1182/blood.V100.2.692 |
